Table 1.
Participant characteristicsa that had viral symptoms (M1–M5) and without symptoms (M5–M9), who donated 4 consecutive human milk samples (once per month) during the COVID-19 pandemic from March 2020 to June 2020.
| Mothers | Viral symptoms | Infant sex | Postpartum time (mo) | Mother’s age | vaccine during pregnancy |
|---|---|---|---|---|---|
| Mother-1, M1 | Viral infection in end-February 2020 flu-like symptoms (fever and headaches) for 1.5 wks | Female | 5 | 29 | None |
| Mother-2, M2 | Fever, chills, body aches, congestion, cough 2/28/2020 to 03/14/2020 | Female | 3 | 32 | Tdap |
| Mother-2, M3 | Cold symptoms from 02/27/20 to 03/05/20; coughing, runny nose, and fever. | Male | 5 | 32 | None |
| Mother-4, M4 | Viral infection from 03/04/20 to 03/13/20. Symptoms: sneezing, headache, fever, vomiting | Female | 5.5 | 23 | Tdap and Rhogam |
| Mother-5, M5 | Sinus infection—headache, congested, sore throat—mid-March 2020 for 2 weeks | Male | 4 | 31 | Tdap |
| Mother-6, M6 | None | Male | 6 | 35 | Influenza and Tdap |
| Mother-7, M7 | None | Male | 3 | 31 | Influenza |
| Mother-8, M8 | None | Male | 3 | 21 | None |
| Mother-9, M9 | None | Female | 3 | 35 | Influenza and Tdap |
aWomen did not have a medical history, medication, and systematic diseases.